DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

00455 TIANDA PHARMA

Trading Add to Porfolio
Index Constituent : None
Major Shareholders FANG Wen Quan (56.72%)
[02607] Shanghai Pharmaceuticals Holding Co., Ltd. (13.05%)
Hongta Tobacco (Group) Limited (9.66%)		 Sector Health Care & Biotechnology
Web Site http://www.tiandapharma.com Tel (852) 2545-3313
Email info@tianda.com Fax (852) 2541-6558
Related Equities N/A
Principal Activities The principal activities of its subsidiaries are R&D, manufacture and sales of pharmaceutical, biotechnology and healthcare products. The Group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top